Ciphergen to Participate at the BIO CEO and Investor Conference
February 09 2007 - 9:00AM
PR Newswire (US)
FREMONT, Calif., Feb. 9 /PRNewswire-FirstCall/ -- Ciphergen
Biosystems, Inc. (NASDAQ:CIPH) announced today that Eric T. Fung,
M.D., Ph.D., Chief Scientific Officer, is scheduled to participate
in an ovarian cancer panel discussion at the BIO CEO and Investor
Conference in New York on Monday, February 12, 2007 at 3:30 p.m. in
the Waldorf's Louis XVI Suite Center/West Room. The therapeutic
workshop entitled, "Treatments Obviously Needed for a
Not-So-Obvious Disease," will address the difficulties in detecting
and treating ovarian cancer and what companies are doing to improve
prognosis for women diagnosed with this disease. About Ciphergen
Ciphergen Biosystems, Inc. is dedicated to the discovery,
development and commercialization of novel high-value diagnostic
tests that help physicians diagnose, treat and improve outcomes for
patients. Ciphergen, along with its prestigious scientific
collaborators, has ongoing diagnostic programs in
oncology/hematology, cardiology and women's health with an initial
focus in ovarian cancer. Based in Fremont, California, more
information about Ciphergen can be found on the web at
http://www.ciphergen.com/ . DATASOURCE: Ciphergen Biosystems, Inc.
CONTACT: Sue Carruthers, Investor Relations of Ciphergen
Biosystems, Inc., +1-510-505-2233; or media, Lori Murray of
WeissComm Partners, +1-415-946-1070, for Ciphergen Biosystems, Inc.
Web site: http://www.ciphergen.com/
Copyright
Ciphergen Biosystems (NASDAQ:CIPH)
Historical Stock Chart
From May 2024 to Jun 2024
Ciphergen Biosystems (NASDAQ:CIPH)
Historical Stock Chart
From Jun 2023 to Jun 2024